MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age

Clinical trial NCT04440163 · COMPLETED

Trial details

NCT number: NCT04440163
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Vaccine

Start date: 2020-06-17
Primary completion: 2022-07-24
Enrollment: 2431

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.